Teva

[dass]

Profile
Introduction | Business | Technologies | Location |
Introduction

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company. It specializes in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients (APIs). In recent years Teva has acquired numerous companies including Novopharm (in 2000), Sicor (2004) and IVAX Corporation (2006). In 2005, Teva had sales of $5.3 billion and employed about 25,000 employees all over the world. The company's shares are the most actively traded on the Tel-Aviv Exchange.
Business

* Human pharmaceuticals: Teva produces generic drugs in all major therapeutics and steriles in a variety of dosage forms, from tablets and capsules to ointments, creams and liquids. It also manufactures innovative drugs in niche markets where it has a relative advantage in research and development.
* Active Pharmaceutical Ingredients (API): Teva uses its API for its own pharmaceutical production as well as to distribute to manufacturers all over the world.

top
Technologies

Teva has collaborations with major universities, hospitals and research institutes in Israel. At present, it has novel treatments for ailments like Parkinson's Disease, Alzheimer's Disease and Epilepsy in clinical research phases.
Location

Headquartered in Israel, Teva has production facilities in Israel, North America, Europe and Latin America.